Grand Challenges in Bio-Nanotechnology to Manage the COVID-19 Pandemic Article

Paliwal, P, Sargolzaei, S, Bhardwaj, SK et al. (2020). Grand Challenges in Bio-Nanotechnology to Manage the COVID-19 Pandemic . 2 10.3389/fnano.2020.571284

cited authors

  • Paliwal, P; Sargolzaei, S; Bhardwaj, SK; Bhardwaj, V; Dixit, C; Kaushik, A

fiu authors


  • The outbreak of the COVID-19, a human beta coronavirus severe acute respiratory syndrome (SARS-CoV-2) virus infection, has severely affected the world. The pandemic is not yet in full control due to a lack of rapid diagnostics and therapeutics. This viral infection continues to result in a steadily increasing loss of life, and it has also emerged as a significant global socio-economic burden. As result, it has united many countries for the purposes of exploring molecular biology, biomedical science, and the nanotechnology to manage COVID-19 successfully. As of today, the current priority is to investigate novel therapies of high efficacy and smart diagnostics tools for early-stage disease diagnostics along with monitoring. Keeping these advancement and challenges in mind, this perspective article mainly highlights the contribution and possibilities of bio-nanotechnology to manage the COVID-19 pandemic, even in a personalized manner. Authors also pinpoint barriers to the utilization of current bio-nanotechnology to facilitate a more accurate understanding of COVID-19 and to lead the way toward personalized health and wellness. Furthermore, we follow the discussion of the features and challenges in upcoming bio-nanotechnology approaches for COVID-19 management. In this progressive option report, bio-nanotechnologies that have been enriched with the power of artificial intelligence and optimized at the personalized level have been found to lead to a sustainable treatment and cure strategy at a global population scale.

publication date

  • November 16, 2020

Digital Object Identifier (DOI)


  • 2